1. Chest Pain in Primary Care: A Systematic Review of Risk Stratification Tools to Rule Out Acute Coronary Syndrome
- Author
-
van den Bulk, Simone, Manten, Amy, Bonten, Tobias N., and Harskamp, Ralf E.
- Subjects
Medical research ,Medicine, Experimental ,Chest pain -- Health aspects ,Acute coronary syndrome -- Diagnosis -- Risk factors ,Primary health care -- Methods ,Health risk assessment -- Research -- Methods ,Health ,Science and technology - Abstract
PURPOSE Chest pain frequently poses a diagnostic challenge for general practitioners (GPs). Utilizing risk stratification tools might help GPs to rule out acute coronary syndrome (ACS) and make appropriate referral decisions. We conducted a systematic review of studies evaluating risk stratification tools for chest pain in primary care settings, both with and without troponin assays. Our aims were to assess the performance of tools for ruling out ACS and to provide a comprehensive review of the current evidence. METHODS We searched PubMed and Embase for articles up to October 9, 2023 concerning adult patients with acute chest pain in primary care settings, for whom risk stratification tools (clinical decision rules [CDRs] and/or single biomarker tests) were used. To identify eligible studies, a combination of active learning and backward snowballing was applied. Screening, data extraction, and quality assessment (following the Quality Assessment of Diagnostic Accuracy Studies-2 tool) were performed independently by 2 researchers. RESULTS Of the 1,204 studies screened, 14 were included in the final review. Nine studies validated 7 different CDRs without troponin. Sensitivities ranged from 75.0% to 97.0%, and negative predictive values (NPV) ranged from 82.4% to 99.7%. None of the CDRs outperformed the unaided judgment of GP's. Five studies reported on strategies using troponin measurements. Studies using high-sensitivity troponin showed highest diagnostic accuracy with sensitivity 83.3% to 100% and NPV 98.8% to 100%. CONCLUSION Clinical decision rules without troponin and the use of conventional troponin showed insufficient sensitivity to rule out ACS in primary care and are not recommended as standalone tools. High-sensitivity troponin strategies are promising, but studies are limited. Further prospective validation in primary care is needed before implementation. Key words: acute coronary syndrome; chest pain; clinical decision rules; primary health care; troponin, https://doi.org/10.1370/afm.3141 INTRODUCTION Chest pain often poses a diagnostic challenge for general practitioners (GPs). While chest pain is the hallmark symptom of acute coronary syndrome (ACS), it is often caused by [...]
- Published
- 2024
- Full Text
- View/download PDF